TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07799207: Effects of Continuous Yogurt Intake on Immunomodulatory Function and Subjective Health Status in Healthy U.S. Adults

Sponsor: Meiji Co., Ltd. · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 118 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$11,040,000

Rescue Site Savings

+$7,279,500

Unlock Full NCT07799207 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07799207 Rescue Dossier →